Promius Pharma

Dr Reddy’s announces closure of the transaction to divest Zembrace SymTouch and Tosymra to Upsher-Smith

Read more

Promius Pharma launches Sernivo (betamethasone dipropionate) spray

Read more

DRL’s migraine drug ZEMBRACE SymTouch launched in US

Read more

Promius Pharma receives FDA approval for Sernivo spray

Read more

Sales rep files sexual harassment claims against DRL, Promius Pharma

Read more

DRL Laboratories signs commercialisation deal with Hatchtech

Read more

DRL, Promius Pharma files NDAs with US FDA

Read more

DRL and its subsidiary Promius Pharma files three NDAs with US FDA

Read more